PHARMACISTS

You are aware that the active pharmaceutical ingredient (API) has pharmacological activity in the diagnosis, cure, mitigation, treatment or prevention of a disease so you want to be sure to sell and distribute a quality product.

With 70 years’ experience in manufacturing high quality active pharmaceutical ingredients, Dipharma guarantees the quality and safety of its products.

Dipharma applies current Good Manufacturing Practices to the API process, from the use of starting materials to final product, and validates the critical process steps that impact the quality and purity of the final API in all its three European manufacturing facilities.

You know that when you give a product that contains Dipharma’s active pharmaceutical ingredient you are giving a quality product which has been manufactured in Europe under the strictest standards of purity and process control.

FAQ

What are the requirements for manufacturing active pharmaceutical ingredients?

The National Agencies of Health as the US Food and Drug Administration (FDA), expect Active Pharmaceutical Ingredient producers to apply Good Manufacturing Practices (cGMP) to the manufacturing process beginning with the use of starting materials and validate critical process steps that impact the quality and purity of the final API. Controls over material quality are expected to increase as the process approaches the final API.

What is meant by current good manufacturing practices?

Good Manufacturing Practice (GMP) is a system of production and testing practices implemented to ensure the quality of a product. Pharmaceutical firms and Active Pharmaceutical Ingredient producers apply the Current Good Manufacturing Practices in order to ensure that the products produced meet defined requirements for identity, strength, quality, and purity.